Research hypothesis

Recent research findings suggest that targeting poor blood flow to endometriosis lesions and concurrent chronic inflammation may reduce endometriosis-related pain and even hinder disease progression. Nutraceuticals contain active ingredients derived from natural origins, that may have a therapeutic benefit. Specially formulated nutraceuticals that target blood vessels and inflammatory pathways are being studied in endometriosis pain context. These nutraceuticals are well tolerated and are novel in

Why is this research important?

Current treatments for endometriosis-related pain are often ineffective and have a range of off-target side effects. It is paramount to research alternative options that have minimal side effects, are non-invasive and are affordable. The MMEND Study aims to understand if vascular active and anti-inflammatory compounds can reduce pain and improve quality of life for endometriosis patients.

How can I get involved?

You may be eligible if you are 18-45 years old, have a diagnosis of endometriosis and experience moderate to severe endometriosis pain regularly.

If you or someone you know would like to know more about this study, please complete the short pre-screening survey below to register your interest.

Study Team Contact details:

Email: mmend@curtin.edu.au
MOB: +61 415 121 435